These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18230721)

  • 1. BRCA1 regulates human mammary stem/progenitor cell fate.
    Liu S; Ginestier C; Charafe-Jauffret E; Foco H; Kleer CG; Merajver SD; Dontu G; Wicha MS
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1680-5. PubMed ID: 18230721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
    Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
    Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
    Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
    Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.
    Heerma van Voss MR; van der Groep P; Bart J; van der Wall E; van Diest PJ
    Cell Oncol (Dordr); 2011 Feb; 34(1):3-10. PubMed ID: 21336637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.
    Honeth G; Lombardi S; Ginestier C; Hur M; Marlow R; Buchupalli B; Shinomiya I; Gazinska P; Bombelli S; Ramalingam V; Purushotham AD; Pinder SE; Dontu G
    Breast Cancer Res; 2014 May; 16(3):R52. PubMed ID: 24887554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
    Lim E; Vaillant F; Wu D; Forrest NC; Pal B; Hart AH; Asselin-Labat ML; Gyorki DE; Ward T; Partanen A; Feleppa F; Huschtscha LI; Thorne HJ; ; Fox SB; Yan M; French JD; Brown MA; Smyth GK; Visvader JE; Lindeman GJ
    Nat Med; 2009 Aug; 15(8):907-13. PubMed ID: 19648928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.
    Madjd Z; Ramezani B; Molanae S; Asadi-Lari M
    Asian Pac J Cancer Prev; 2012; 13(6):2973-8. PubMed ID: 22938492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.
    Burga LN; Tung NM; Troyan SL; Bostina M; Konstantinopoulos PA; Fountzilas H; Spentzos D; Miron A; Yassin YA; Lee BT; Wulf GM
    Cancer Res; 2009 Feb; 69(4):1273-8. PubMed ID: 19190334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
    Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
    Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
    Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
    Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
    Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
    Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers.
    Heerma van Voss MR; van der Groep P; Bart J; van der Wall E; van Diest PJ
    Breast Cancer Res Treat; 2010 Sep; 123(2):611-2. PubMed ID: 20585849
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell fate takes a slug in BRCA1-associated breast cancer.
    Lindeman GJ; Visvader JE
    Breast Cancer Res; 2011 Apr; 13(2):306. PubMed ID: 21489318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells.
    Kang L; Guo Y; Zhang X; Meng J; Wang ZY
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):262-8. PubMed ID: 21907803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
    Zvelebil M; Oliemuller E; Gao Q; Wansbury O; Mackay A; Kendrick H; Smalley MJ; Reis-Filho JS; Howard BA
    Breast Cancer Res; 2013 Mar; 15(2):R25. PubMed ID: 23506684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.
    Molyneux G; Smalley MJ
    J Mammary Gland Biol Neoplasia; 2011 Apr; 16(1):51-5. PubMed ID: 21336547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit.
    Smart CE; Wronski A; French JD; Edwards SL; Asselin-Labat ML; Waddell N; Peters K; Brewster BL; Brooks K; Simpson K; Manning N; Lakhani SR; Grimmond S; Lindeman GJ; Visvader JE; Brown MA
    Oncogene; 2011 Mar; 30(13):1597-607. PubMed ID: 21132007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
    Wang H; Bierie B; Li AG; Pathania S; Toomire K; Dimitrov SD; Liu B; Gelman R; Giobbie-Hurder A; Feunteun J; Polyak K; Livingston DM
    Mol Cell; 2016 Jul; 63(2):277-292. PubMed ID: 27373334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.